Inactive Instrument

News BROE CAPI

Equities

BCAC

US11374E1047

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

BROE CAPI27 : INDEX TO UNAUDITED CONDENSED FINANCIAL STATEMENTS - Form 8-K/A	22-08-18	PU
Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-18	CI
BROE CAPI27 : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	22-08-04	PU
Brookline Capital Acquisition : Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company - Form 8-K	22-08-01	PU
Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) dropped from NASDAQ Composite Index	22-07-29	CI
Apexigen Inc. completed the acquisition of Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others in a reverse merger transaction.	22-07-28	CI
BROOKLINE CAPITAL ACQUISITION : AND APEXIGEN, INC. ANNOUNCE STOCKHOLDER APPROVAL OF BUSINESS COMBINATION - Form 8-K	22-07-28	PU
Brookline Capital Acquisition : Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement and Annual Stockholder Meeting to Approve the Proposed Business Combination - Form 8-K	22-07-18	PU
Brookline Capital Acquisition : Confirms Receipt of Sponsor Funds to Extend Period of Time to Consummate Business Combination and for Additional Working Capital - Form 8-K	22-06-30	PU
Brookline Capital Acquisition : Quarterly Report (Form 10-Q)	22-05-23	PU
Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Brookline Capital Acquisition Corp. announced that it has received $0.167032 million in funding from Brookline Capital Holdings, LLC	22-05-01	CI
Brookline Capital Acquisition : Announces Stockholder Approval of Extension Amendment to Complete its Business Combination with Apexigen, Inc - Form 8-K	22-04-26	PU
Brookline Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-07	CI
Brookline Capital Acquisition Corp. Auditor Raises 'Going Concern' Doubt	22-04-06	CI
Brookline Capital Acquisition : VIAVID communications simplified. Apexigen and Brookline Capital Acquisition Corp. Joint Conference Call - Form 8-K	22-03-18	PU
Brookline Capital Acquisition : Apexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology Company - Form 8-K	22-03-18	PU
Blank Check Firm Brookline Capital Acquisition, Apexigen Enter Merger Agreement	22-03-18	MT
Apexigen Inc. entered into a non-binding letter of intent to acquire Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others for approximately $210 million in a reverse merger transaction.	22-03-17	CI
Brookline Capital Acquisition : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - Form 8-K	21-12-15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BROE CAPI

Equities

BCAC

US11374E1047

Summary

Filters